Journal for the AI review of human MICU1 (mitochondrial calcium uptake 1; originally CBARA1,
"calcium-binding atopy-related autoantigen 1"). 114 GOA rows, 26 distinct GO terms.
MICU1 is an EF-hand Ca2+-binding protein that sits on the intermembrane-space face of the inner
mitochondrial membrane, where it associates with the MCU/EMRE pore to form the uniporter
holocomplex (uniplex) and gates Ca2+ entry into the matrix.
Occlusion vs potentiation. GOA holds three IDA annotations to GO:0019855 calcium channel inhibitor
activity (PMID:32494073, PMID:37036971, PMID:37126688), and the 2023 pair were written explicitly
to settle a "direct clash"
PMID:37036971,
PMID:37126688.
Both sides agree MICU1 sets the threshold; they disagree on whether the low-Ca2+ state is physical
occlusion or allosteric potentiation. The occlusion side now has direct patch-clamp support, so the
inhibitor-activity annotations are kept.
MICU1 already has two published uniporter-independent roles, both in GOA:
There is also a hard genetic argument that predates all of this: Micu1 null lethality is not rescued
by removing the uniporter
PMID:42129466.
So "MICU1 does things without MCU" is established. The 2026 claim is a different and larger one.
Cohen et al., Nat Metab 2026 (PMID:42129466), from the Elrod lab (the same lab as the 2023 MICOS
paper).
What it demonstrates:
PMID:42129466
MICU1-specific evidence includes a co-IP with the relevant dehydrogenase
PMID:42129466.
What it proposes:
PMID:42129466
Note the hedging in the body: "Our results suggest that this may be the primary physiological
calcium signaling mechanism regulating cellular energetics."
It does not claim MICU1 has stopped being a gatekeeper. The paper's own framing keeps that intact:
PMID:42129466
The model it displaces is the downstream dogma that matrix [Ca2+], delivered through the uniporter,
is what activates the matrix dehydrogenases and thereby tunes basal energetics. That dogma is not
itself a MICU1 GO annotation. So the mapping from this paper onto MICU1's annotation set is narrower
than the abstract's rhetoric suggests:
| Claim in PMID:42129466 | Effect on MICU1 GO annotations |
|---|---|
| MICU proteins scaffold a Ca2+-sensitive GPD2/SDH metabolon | New function; no existing GO term captures it |
| MICU heterodimerisation is mtCU-independent | Supports existing GO:0046982, no change |
| MICU1 still gates mtCU | Supports GO:0019855, GO:0061891, GO:1990246, GO:0036444 |
| Matrix Ca2+ is not the master regulator of basal metabolism | Not a MICU1 annotation; nothing to retract |
One paper, one lab, no independent replication and no published rebuttal. I checked: a PubMed
search for MICU metabolon returns exactly two records, PMID:42129466 and PMID:40678212 — and the
second is the Research Square preprint of the same study, not an independent confirmation. A search
for MICU1 GPD2 returns nothing else at all. Meanwhile the field has gone on using the gatekeeper
model after publication, e.g. an August 2026 Exp Mol Med study describes the uniporter as one that
PMID:42557311.
That is not a rebuttal either, but it does show the standing model is still in working use. That asymmetry means the claim is untested, not that it is
accepted. The primacy assertion ("the primary physiological calcium signaling mechanism") is a
proposal about relative importance, which is not the sort of thing a GO annotation should encode
even if it were settled. Accordingly:
proposed_new_terms candidate and insuggested_questions, not folded into core_functions.If replication follows, the right GO representation is probably an MF in the enzyme-regulator branch
(regulation of GPD2/SDH activity) plus a part_of a named metabolon complex, neither of which exists
yet.
CC -!- ALLERGEN: Causes an allergic
reaction in human. Binds to IgE from atopic dermatitis (AD) patients. (MICU1-uniprot.txt line 690).Disease context (not itself annotated, but it constrains how essential the gene is): biallelic
loss-of-function causes myopathy with extrapyramidal signs, MPXPS, MIM:615673 — early-onset proximal
muscle weakness, raised creatine kinase, learning difficulties and progressive involuntary movement
(UniProt DISEASE block, MICU1-uniprot.txt lines 671–685).
ACCEPT: GO:0005509, GO:0005739, GO:0005743, GO:0005758, GO:0006851, GO:0019855, GO:0036444,
GO:0044284, GO:0046982, GO:0051560, GO:0051561, GO:0061891, GO:1903852, GO:1990246
KEEP_AS_NON_CORE: GO:0042802, GO:0051260, GO:0071277
MODIFY: GO:0031966 → GO:0005743; GO:0034704 → GO:1990246; GO:0070509 → GO:0036444
MARK_AS_OVER_ANNOTATED: GO:0005515, GO:0072732, GO:1900069
REMOVE: GO:0006952